Early identification of atherosclerotic disease by noninvasive imaging

[1]  M. Pencina,et al.  C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study , 2008, Circulation. Cardiovascular quality and outcomes.

[2]  Michael J. Pencina,et al.  Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[3]  V. Fuster,et al.  Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study , 2009, Circulation. Cardiovascular imaging.

[4]  Zahi A Fayad,et al.  Imaging atherosclerotic plaque inflammation , 2008, Nature Clinical Practice Cardiovascular Medicine.

[5]  H. Sillesen,et al.  Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  Yoram Rudy,et al.  From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. , 2006, The American journal of cardiology.

[7]  P. Whincup,et al.  How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study , 2008, Circulation.

[8]  V. Fuster,et al.  Neovascularization in human atherosclerosis. , 2006, Current molecular medicine.

[9]  Alan D. Lopez,et al.  the Global Burden of Disease , 2004 .

[10]  L. Smeeth,et al.  Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. , 2009, International journal of epidemiology.

[11]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[12]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[13]  M. Hahne,et al.  Cell Death , 2010, Cell Death and Differentiation.

[14]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[15]  Renu Virmani,et al.  Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. , 2009, Journal of the American College of Cardiology.

[16]  N. Paynter,et al.  C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.

[17]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[18]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[19]  V. Fuster,et al.  Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. , 2009, Journal of the American College of Cardiology.

[20]  Milind Y Desai,et al.  Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging–Monitored Therapy , 2004, Circulation.

[21]  J. Liao,et al.  Notch Signaling Regulates Endothelial Progenitor Cell Activity During Recovery From Arterial Injury in Hypercholesterolemic Mice , 2010, Circulation.

[22]  Robert Beaglehole,et al.  Global public health: a scorecard , 2008, The Lancet.

[23]  Susan M Sawyer,et al.  Global patterns of mortality in young people: a systematic analysis of population health data , 2009, The Lancet.

[24]  Bridget B. Kelly,et al.  Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health , 2010 .

[25]  B. Brüne,et al.  Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms. , 2003, Blood.

[26]  V. Fuster,et al.  Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[27]  V. Fuster,et al.  Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.

[28]  V. Fuster,et al.  The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectives. , 2010, American heart journal.

[29]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[30]  Matthias Stuber,et al.  Controversies in cardiovascular medicine series Imaging of the unstable plaque : how far have we got ? , 2009 .

[31]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[32]  W S Kerwin,et al.  MR imaging of adventitial vasa vasorum in carotid atherosclerosis , 2008, Magnetic resonance in medicine.

[33]  V. Fuster,et al.  The CVD paradox: mortality vs prevalence , 2009, Nature Reviews Cardiology.

[34]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[35]  W. B. Meijboom,et al.  Reliable high-speed coronary computed tomography in symptomatic patients. , 2007, Journal of the American College of Cardiology.

[36]  Jie Zhou,et al.  Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1 (HIF-1 ) accumulation via redox-dependent mechanisms , 2003 .

[37]  Gemma Vilahur,et al.  Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. , 2008, Journal of the American College of Cardiology.

[38]  V. Fuster,et al.  Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[39]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[40]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[41]  Pauliina Lehtolainen,et al.  Magnetic tagging increases delivery of circulating progenitors in vascular injury. , 2009, JACC. Cardiovascular interventions.

[42]  Chun Yuan,et al.  MRI of carotid atherosclerosis: clinical implications and future directions , 2010, Nature Reviews Cardiology.

[43]  Simon Capewell,et al.  Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000 , 2004, Circulation.

[44]  D. Berman,et al.  Evidence-based risk assessment in noninvasive imaging. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  V. Fuster,et al.  The human high-risk plaque and its detection by magnetic resonance imaging. , 2001, The American journal of cardiology.

[46]  Zahi A Fayad,et al.  Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[47]  R. Hotchkiss,et al.  Cell death. , 2009, The New England journal of medicine.

[48]  V. Salomaa,et al.  Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. , 2005, American journal of epidemiology.

[49]  W. Brown.  Framingham Heart Study. , 2011, Journal of clinical lipidology.

[50]  Simon Capewell,et al.  Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. , 2009, American journal of epidemiology.

[51]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[52]  R. Bonow.  Clinical practice. Should coronary calcium screening be used in cardiovascular prevention strategies? , 2009, The New England journal of medicine.

[53]  D. Berman,et al.  Role of noninvasive imaging in asymptomatic high-risk patients. , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[54]  P. Raggi,et al.  Calcification in atherosclerosis , 2009, Nature Reviews Cardiology.

[55]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.